These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12614732)

  • 1. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients.
    Singh N
    Lancet Infect Dis; 2003 Mar; 3(3):156-61. PubMed ID: 12614732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens.
    Singh N
    Curr Opin Infect Dis; 2005 Aug; 18(4):342-5. PubMed ID: 15985832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation.
    Helfrich M; Dorschner P; Thomas K; Stosor V; Ison MG
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious diseases in the liver transplant recipient.
    Singh N
    Semin Gastrointest Dis; 1998 Jul; 9(3):136-46. PubMed ID: 9700844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials.
    Husain S; Singh N
    Clin Infect Dis; 2002 Jul; 35(1):53-61. PubMed ID: 12060875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
    Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F; Mohsin N; Kamble P
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different behaviour of BK-virus infection in liver transplant recipients.
    Umbro I; Tinti F; Muiesan P; Mitterhofer AP
    World J Gastroenterol; 2016 Jan; 22(4):1532-40. PubMed ID: 26819520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the immunosuppressive regimen on the incidence of cytomegalovirus infection in 378 heart transplant recipients: A single centre, prospective cohort study.
    Durante-Mangoni E; Andini R; Pinto D; Iossa D; Molaro R; Agrusta F; Casillo R; Grimaldi M; Utili R
    J Clin Virol; 2015 Jul; 68():37-42. PubMed ID: 26071333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections in immunocompromised hosts and organ transplant recipients: essentials.
    Fishman JA
    Liver Transpl; 2011 Nov; 17 Suppl 3():S34-7. PubMed ID: 21748845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections in solid organ transplant HIV-infected patients.
    Miro JM; Agüero F; Duclos-Vallée JC; Mueller NJ; Grossi P; Moreno A;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():119-30. PubMed ID: 25040016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiologic consequences of new approaches to managing hematologic malignancies.
    Blijlevens NM; Donnelly JP; de Pauw BE
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
    Singh N
    Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management.
    Singh N; Husain S
    J Heart Lung Transplant; 2003 Mar; 22(3):258-66. PubMed ID: 12633692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic deep cutaneous mycoses in solid organ transplant recipients.
    Tessari G; Cagalli A; Girolomoni G
    G Ital Dermatol Venereol; 2014 Aug; 149(4):417-22. PubMed ID: 25068229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive fungal infections in renal transplant recipients: about 11 cases.
    Trabelsi H; Néji S; Sellami H; Yaich S; Cheikhrouhou F; Guidara R; Charffedine K; Makni F; Hachicha J; Ayadi A
    J Mycol Med; 2013 Dec; 23(4):255-60. PubMed ID: 24060353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].
    Quindós G
    Rev Iberoam Micol; 2011; 28(3):110-9. PubMed ID: 21700230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive aspergillosis in organ transplant recipients: new issues in epidemiologic characteristics, diagnosis, and management.
    Singh N
    Med Mycol; 2005 May; 43 Suppl 1():S267-70. PubMed ID: 16110819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients.
    Singh N; Heitman J
    Transplantation; 2004 Mar; 77(6):795-800. PubMed ID: 15077015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.